drugset / Trial / NCT01967225
Safety and Efficacy of BAY1192631 in Japanese Patients With Methicillin-resistant Staphylococcus Aureus (MRSA) Infections
RandomizedParallel-groupOpen-labelTreatment
Summary
The aim of this study is to see the efficacy and safety of BAY1192631 in Japanese patients with methicillin-resistant staphylococcus aureus (MRSA) (skin and soft tissue infections (SSTI) and SSTI-related bacteremia).
Timeline
- Start
- 2013-11-23
- Primary completion
- 2016-10-28
- Completion
- 2016-10-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Linezolid | Other / unclassified | 600 mg | Intravenous |
| Subject | Tedizolid | Small molecule | 200 mg | Intravenous |